Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:167-174
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bin, J.-P.
Right arrow Articles by Kaul, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bin, J.-P.
Right arrow Articles by Kaul, S.

Dobutamine versus dipyridamole for inducing reversible perfusion defects in chronic multivessel coronary artery stenosis

Jian-Ping Bin, MD*, Robert A. Pelberg, MD*, Kevin Wei, MD, FACC*, D. Elizabeth Le, MD*, N. Craig Goodman, BS* and Sanjiv Kaul, MD, FACC*,*

* Cardiovascular Imaging Center, the Cardiovascular Division, University of Virginia, Charlottesville, Virginia, USA



View larger version (17K):

[in a new window]
 
Figure 1 Relationship of the ratio of myocardial blood flow (MBF) between abnormal and normal beds (those with transmural MBF reserve of <3 and ≥3, respectively, x-axis) during dipyridamole (filled circles) and dobutamine (open circles) versus ratio myocardial blood volume (A) from the two beds (y-axis).

 


View larger version (15K):

[in a new window]
 
Figure 2 Relationship between radiolabeled microsphere-derived myocardial blood flow (MBF) reserve (x-axis) and myocardial contrast echocardiography-derived A reserve (y-axis) in the presence of dipyridamole (filled circles) and dobutamine (open circles).

 


View larger version (15K):

[in a new window]
 
Figure 3 Relationship between radiolabeled microsphere-derived myocardial blood flow (MBF) reserve (x-axis) and myocardial contrast echocardiography-derived ß reserve (y-axis) in the presence of dipyridamole (filled circles) and dobutamine (open circles).

 


View larger version (17K):

[in a new window]
 
Figure 4 Relationship of the ratio of myocardial blood flow (MBF) between abnormal and normal beds (those with transmural MBF reserve if <3 and ≥3, respectively, x-axis) during dipyridamole (filled circles) and dobutamine (open circles) versus ratio of ß from the two beds (y-axis).

 


View larger version (17K):

[in a new window]
 
Figure 5 Relationship of the ratio of myocardial blood flow (MBF) between abnormal and normal beds (those with transmural MBF reserve if <3 and ≥3, respectively, x-axis) during dipyridamole (filled circles) and dobutamine (open circles) versus ratio of the product A·ß from the two beds (y-axis).

 


View larger version (15K):

[in a new window]
 
Figure 6 Relationship between radiolabeled microsphere-derived myocardial blood flow (MBF) reserve (x-axis) and myocardial contrast echocardiography-derived A·ß reserve (y-axis) in the presence of dipyridamole (filled circles) and dobutamine (open circles).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement